Sea Mild Biotechnology Co., Ltd. (7516.TWO)
TWD 10.3
(-1.44%)
TWD 10.3
(-1.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.03 Million | 13.17 Million | -12.4 Million | 2.62 Million | -63.28 Million | -26.86 Million |
| Net Income | 6.18 Million | -21.38 Million | -52.05 Million | -55.5 Million | -159.12 Million | 66 Thousand |
| Depreciation & Amortization | 14.48 Million | 15.16 Million | 20.83 Million | 20.88 Million | 20.55 Million | 4.12 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -16.49 Million | 10.43 Million | 3.59 Million | 23.57 Million | 21.08 Million | -19.64 Million |
| Other non-cash items | 42.41 Million | 31.44 Million | 53.33 Million | 23.53 Million | 117.34 Million | 10.15 Million |
| Investing Cash Flow | -13.65 Million | -2.3 Million | 9.87 Million | 1.42 Million | -45.42 Million | 126.75 Million |
| Investments in PPE | -2.86 Million | -326 Thousand | -3.39 Million | -16.73 Million | -45.42 Million | -12.41 Million |
| Acquisitions | - | 345 Thousand | 55 Thousand | 15.15 Million | - | 139.17 Million |
| Investment purchases | -10.78 Million | -2.32 Million | -1.14 Million | 3 Million | - | - |
| Sales/Maturities of investments | - | - | 13.57 Million | 3 Million | - | - |
| Other Investing Activities | -1.62 Million | -41 Thousand | 798 Thousand | 9.05 Million | - | - |
| Financing Cash Flow | 16.65 Million | -9.28 Million | -10.61 Million | 611 Thousand | 73.85 Million | -24.23 Million |
| Debt repayment | -27.75 Million | -1.58 Million | -52 Thousand | -10.1 Million | -51.4 Million | -79.92 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 148.31 Million | 54 Million |
| Other Financing Activities | -11.1 Million | - | - | -945 Thousand | 945 Thousand | 1.68 Million |
| Accounts receivables | -590 Thousand | -7.09 Million | -38 Thousand | 34.25 Million | -35.51 Million | -18.85 Million |
| Accounts payables | -1.96 Million | 10.57 Million | -3.86 Million | -13.21 Million | 6.87 Million | 4.08 Million |
| Inventory | -12.03 Million | 4.37 Million | 7.44 Million | 10.86 Million | 6.62 Million | 1.44 Million |
| Other working capital | -1.89 Million | 2.57 Million | 50 Thousand | -8.33 Million | 43.09 Million | -6.32 Million |
| Cash at beginning of period | 40.57 Million | 38.94 Million | 52.06 Million | 50.15 Million | 89.31 Million | 13.71 Million |
| Cash at end of period | 46.62 Million | 40.57 Million | 38.94 Million | 52.06 Million | 50.15 Million | 89.31 Million |
| Capital Expenditure | -2.86 Million | -326 Thousand | -3.39 Million | -16.73 Million | -45.42 Million | -12.41 Million |
| Effect of forex changes on cash | 16 Thousand | 45 Thousand | 13 Thousand | 254 Thousand | - | - |
| Net cash flow / Change in cash | 6.05 Million | 1.63 Million | -13.12 Million | 1.91 Million | -39.16 Million | 75.6 Million |
| Free Cash Flow | 163 Thousand | 12.85 Million | -15.8 Million | -14.11 Million | -108.7 Million | -39.27 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.9 Million | 7.9 Million | 6.18 Million | 1.84 Million | 1.84 Million | 1.25 Million |
| Depreciation & Amortization | 3.9 Million | 3.9 Million | 14.48 Million | 3.97 Million | 3.97 Million | 3.26 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -14.28 Million | -14.28 Million | -16.49 Million | -30.5 Thousand | -30.5 Thousand | -4.16 Million |
| Other non-cash items | 317.5 Thousand | 317.5 Thousand | 42.41 Million | -4.02 Million | -4.02 Million | 2.31 Million |
| Investing Cash Flow | -3.65 Million | -3.65 Million | -13.65 Million | -2.35 Million | -2.35 Million | -4.46 Million |
| Investments in PPE | -1.11 Million | -1.11 Million | -2.86 Million | -623.5 Thousand | -623.5 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -10.78 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.54 Million | -2.54 Million | -1.62 Million | -1.73 Million | -1.73 Million | -4.46 Million |
| Financing Cash Flow | 14.21 Million | 14.21 Million | 16.65 Million | 4.41 Million | 4.41 Million | 1.01 Million |
| Debt repayment | - | - | -27.75 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 14.21 Million | 14.21 Million | - | 4.41 Million | 4.41 Million | 1.01 Million |
| Accounts receivables | -10.83 Million | -10.83 Million | -590 Thousand | 6.34 Million | 6.34 Million | -5.61 Million |
| Accounts payables | - | - | -1.96 Million | - | - | - |
| Inventory | -6.55 Million | -6.55 Million | -12.03 Million | -2.79 Million | -2.79 Million | -3.22 Million |
| Other working capital | 3.11 Million | 3.11 Million | -1.89 Million | -3.57 Million | -3.57 Million | 4.66 Million |
| Cash at beginning of period | - | - | 40.57 Million | - | 38.9 Million | 39.74 Million |
| Cash at end of period | 8.39 Million | 8.39 Million | 46.62 Million | 3.86 Million | 42.76 Million | 38.9 Million |
| Capital Expenditure | -1.11 Million | -1.11 Million | -2.86 Million | -623.5 Thousand | -623.5 Thousand | - |
| Effect of forex changes on cash | - | - | 16 Thousand | 50.5 Thousand | 50.5 Thousand | -42.5 Thousand |
| Net cash flow / Change in cash | 8.39 Million | 8.39 Million | 6.05 Million | 3.86 Million | 3.86 Million | -835 Thousand |
| Free Cash Flow | -3.27 Million | -3.27 Million | 163 Thousand | 1.13 Million | 1.13 Million | 2.66 Million |
GRF
PSNY
9105
UONE
4671
NBIFIN